After comparing the NGS sequencing results of each group of samples, only 3 sites of EZH2 mutation were found in the primary lesion of lung cancer, while 20 mutation sites were found in metastatic cancer tissue. The gene discussed is EZH2; the disease is metastatic malignant neoplasm.